The CMTA is a global leader in the acceleration of CMT research and pre-clinical testing. The CMTA team will be attending the PNS annual meeting in Copenhagen and have availability for partner meetings from Sunday 18th June to Tuesday 20th June.
Mark Scheideler, Alliance Partner Lead, and Katherine Forsey, Chief Research Officer, will be attending the conference along with members of the CMTA’s STAR Advisory Board. It’s the perfect opportunity to get to know our capabilities and explore your CMT focused projects with our expert team. You’ll also be able to find us at the CMTA Booth in the exhibition hall.
Please reach out to Mark on mark@hftherapeutics.com to share your needs and book a meeting slot. We’re keen to explore collaborations, research questions and pre-clinical testing needs with biotech and pharma groups, academic labs and patient advocacy partners.”